<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Epilim preparations; Valproate: epilepsy" /><meta name="IX" content="Epilim preparations; Valproate: epilepsy" /><title>Epilim Chrono®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP2989-epilim-chrono.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP2989-epilim-chrono.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP2989-epilim-chrono.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 08 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP2092-central-nervous-system.htm">4 Central nervous system</a> &gt; <a href="PHP2897-antiepileptic-drugs.htm">4.8 Antiepileptic drugs</a> &gt; <a href="PHP2898-control-of-the-epilepsies.htm">4.8.1 Control of the epilepsies</a> &gt; <a href="PHP2977-valproate.htm">Valproate</a> &gt; <a href="PHP2978-sodium-valproate.htm">SODIUM VALPROATE</a> &gt; <a href="PHP2988-modified-release.htm">Modified release</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP2977-valproate.htm" title="Previous: Valproate">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP2999-vigabatrin.htm" title="Next: Vigabatrin">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a382412.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Valproate Sodium, Valproic Acid, Divalproex Sodium</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Central Nervous System Agents 28:00 &gt; Anticonvulsants 28:12 &gt; Anticonvulsants, Miscellaneous 28:12.92</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/10447-z.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Valproate</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: V &gt; Interactions of Valproate</p></div></li></ul><ul><li><h3>British National Formulary (16)</h3></li><li><a href="PHP2330-valproate.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Valproate</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.2 Drugs used in psychoses and related disorders &gt; 4.2.3 Antimanic drugs</p></div></li><li><a href="PHP2331-valproic-acid.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">VALPROIC ACID</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.2 Drugs used in psychoses and related disorders &gt; 4.2.3 Antimanic drugs &gt; Valproate</p></div></li><li><a href="PHP2332-depakote.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Depakote®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.2 Drugs used in psychoses and related disorders &gt; 4.2.3 Antimanic drugs &gt; Valproate &gt; VALPROIC ACID</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22sodium+valproate%22%22valproate%22%22sodium+valproate%22%22valproate%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (16)</a></li></ul><ul><li><h3>BNF for Children (13)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP12184-valproate.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Valproate</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 4 Central nervous system &gt; 4.2 Drugs used in psychoses and related disorders &gt; 4.2.3 Antimanic drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP12439-focal-seizures-with-or-without-secondary-generalisation.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Focal seizures with or without secondary generalisation</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptics &gt; 4.8.1 Control of the epilepsies</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP12440-generalised-seizures.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Generalised seizures</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptics &gt; 4.8.1 Control of the epilepsies</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22sodium+valproate%22%22valproate%22%22sodium+valproate%22%22valproate%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (13)</a></li></ul><ul><li><h3>Handbook on Injectable Drugs</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a502009.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Valproate Sodium</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; V</p></div></li></ul><ul><li><h3>Injectable Drugs Guide</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/s11-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Sodium valproate (valproate sodium)</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; S</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/ms-10447-z.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Valproate</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antiepileptics &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/999919-n3985-k.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Gastro-resistant Sodium Valproate Tablets BP 2012 (Pharmacopoeial)</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Preparations &gt; By country &gt; Pharmacopoeial &gt; G</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-D93.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Divalproex Sodium</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; D</p></div></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-V4.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Valproate Sodium</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; V</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E8E3E0R0D87.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Valproate</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; V</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c345.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Sodium valproate</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; S</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>SODIUM VALPROATE</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int286-valproate.htm">Valproate</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">all forms of epilepsy; migraine prophylaxis [unlicensed] (<a title="BNF:sub-sub-section: Prophylaxis of migraine" href="PHP2872-prophylaxis-of-migraine.htm">section 4.7.4.2</a>); mania (<a title="BNF:monograph-family: Valproate" href="PHP2330-valproate.htm">section 4.2.3</a>)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">monitor liver function before therapy and during first 6 months especially in patients most at risk (see also below); measure full blood count and ensure no undue potential for bleeding before starting and before surgery; systemic lupus erythematosus; false-positive urine tests for ketones; avoid abrupt withdrawal; consider vitamin D supplementation in patients that are immobilised for long periods or who have inadequate sun exposure or dietary intake of calcium; <strong>interactions: </strong> see   <a title="target-block: Interactions in epilepsy" href="PHP2898-control-of-the-epilepsies.htm#PHP2899">Interactions</a> in section 4.8.1 and Appendix 1 (valproate)</p></div> <div id="PHP2980" class="cG"><div class="cE"><h3 class="cT">Liver toxicity</h3> <p class="cT">Liver dysfunction (including fatal hepatic failure) has occurred in association with valproate (especially in children under 3 years and in those with metabolic or degenerative disorders, organic brain disease or severe seizure disorders associated with mental retardation) usually in first 6 months and usually involving multiple antiepileptic therapy. Raised liver enzymes during valproate treatment are usually transient but patients should be reassessed clinically and liver function (including prothrombin time) monitored until return to normal—discontinue if abnormally prolonged prothrombin time (particularly in association with other relevant abnormalities).</p></div></div> <div class="cG"><div class="cE"><h3 class="cT">Blood or hepatic disorders</h3> <p class="cT">Patients or their carers should be told how to recognise signs and symptoms of blood or liver disorders and advised to seek immediate medical attention if symptoms develop</p></div></div> <div class="cG"><div class="cE"><h3 class="cT">Pancreatitis</h3> <p class="cT">Patients or their carers should be told how to recognise signs and symptoms of pancreatitis and advised to seek immediate medical attention if symptoms such as abdominal pain, nausea, or vomiting develop; discontinue if pancreatitis is diagnosed</p></div></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Contra-indications </h2> <p class="cT">family history of severe hepatic dysfunction; acute porphyria (<a title=" Acute porphyrias" href="PHP6363-acute-porphyrias.htm">section 9.8.2</a>)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">avoid if possible—hepatotoxicity and hepatic failure may occasionally occur (usually in first 6 months); avoid in active liver disease; see also under Cautions</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">reduce dose</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">see <a title="BNF:target-block: Pregnancy and breast-feeding in epilepsy" href="PHP2898-control-of-the-epilepsies.htm#PHP2903">Pregnancy</a>; neonatal bleeding (related to hypofibrinaemia) and neonatal hepatotoxicity also reported</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">see <a title="BNF:target-block: breast-feeding control of epilepsy" href="PHP2898-control-of-the-epilepsies.htm#PHP2904">Breast-feeding</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">nausea, gastric irritation, diarrhoea; weight gain; hyperammonaemia, thrombocytopenia; transient hair loss (regrowth may be curly); <em>less frequently</em> increased alertness, aggression, hyperactivity, behavioural disturbances, ataxia, tremor, and vasculitis; <em>rarely</em> hepatic dysfunction (see under Cautions; withdraw treatment immediately if persistent vomiting and abdominal pain, anorexia, jaundice, oedema, malaise, drowsiness, or loss of seizure control), lethargy, drowsiness, confusion, stupor, hallucinations, blood disorders (including anaemia, leucopenia, pancytopenia), hearing loss, and rash; <em>very rarely</em> pancreatitis (see under Cautions), peripheral oedema, increase in bleeding time, extrapyramidal symptoms, dementia, encephalopathy, coma, gynaecomastia, Fanconi's syndrome, hirsutism, acne, enuresis, hyponatraemia, toxic epidermal necrolysis, and Stevens-Johnson syndrome; suicidal ideation; reduced bone mineral density (see Cautions); <em>also reported</em> menstrual disturbances, male infertility, syndrome of inappropriate secretion of antidiuretic hormone</p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul> <li><p>Epilepsy, <span class="cK">by mouth</span>, initially 600 mg daily in 1–2 divided doses, increased gradually (in steps of 150–300 mg) every 3 days; usual maintenance dose 1–2 g daily (20–30 mg/kg daily), max. 2.5 g daily; <span class="cP">child</span> 1 month–12 years, initially 10–15 mg/kg (max. 600 mg) daily in 1–2 divided doses; usual maintenance dose 25–30 mg/kg daily in 2 divided doses</p> <p>Initiation of valproate treatment by <span class="cK">intravenous administration</span>, <span class="cP">adult</span> and <span class="cP">child</span> over 12 years, initially 10 mg/kg (usually 400–800 mg) by <span class="cK">intravenous injection</span> (over 3–5 minutes) followed by <span class="cK">intravenous infusion</span> <em>or</em> <span class="cK">intravenous injection</span> (over 3–5 minutes) in 2–4 divided doses <em>or</em> by <span class="cK">continuous intravenous infusion</span> up to max. 2.5 g daily; usual range 1–2 g daily (20–30 mg/kg daily); <span class="cP">child</span> 1 month–12 years, 10 mg/kg by <span class="cK">intravenous injection</span> (over 3–5 minutes) followed by <span class="cK">intravenous infusion</span> <em>or</em> <span class="cK">intravenous injection</span> (over 3–5 minutes) in 2–4 divided doses <em>or</em> by <span class="cK">continuous intravenous infusion</span> up to usual range 20–40 mg/kg daily (doses above 40 mg/kg daily monitor clinical chemistry and haematological parameters)</p> <p>Continuation of valproate treatment by <span class="cK">intravenous injection</span> (over 3–5 minutes) <em>or</em> <span class="cK">intravenous infusion</span> in 2–4 divided doses, or by <span class="cK">continuous intravenous infusion</span>, same as established oral daily dose</p> </li> <li><p>Migraine prophylaxis [unlicensed], <span class="cK">by mouth</span>, initially 200 mg twice daily, increased if necessary to 1.2–1.5 g daily in divided doses</p> </li> <li><p>Mania, see under <em>Episenta</em>®</p> </li> </ul></div></div> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_PHP2985-oral_PHP2985-oral"><a href="PHP2985-oral.htm#PHP2985-oral" title="Oral">Oral</a><ul style="display: none"><li><a href="PHP2986-sodium-valproate-non-proprietary.htm#PHP2986-sodium-valproate-non-proprietary" title="Sodium Valproate">Sodium Valproate</a></li><li><a href="PHP2987-epilim.htm#PHP2987-epilim" title="Epilim®">Epilim®</a></li></ul></li></ul><div id="PHP2988-modified-release" style="margin: 0 0 0 20px;"><h1 class="title">Modified release</h1><div id="PHP2989-epilim-chrono" style="margin: 0 0 0 20px;"><h1 class="title">Epilim Chrono® <span>(<a href="PHP10005-index-of-manufacturers.htm#PHP10320">Sanofi-Aventis</a>)</span><span> <img src="images/pom_l.png" alt="Prescription only medicine" /></span></h1><div class="cU"><p><strong>Tablets</strong>, m/r, lilac, sodium valproate 200 mg (as sodium valproate and valproic acid), net price 100-tab pack = £11.65; 300 mg, 100-tab pack = £17.47; 500 mg, 100-tab pack = £29.10. Label: 8, 21, 25, counselling, pancreatitis, blood, or hepatic disorder symptoms (see <a title="target-block: valproate disorders" href="PHP2978-sodium-valproate.htm#PHP2980">above</a>), driving (see <a title="target-block: Driving and epilepsy" href="PHP2898-control-of-the-epilepsies.htm#PHP2902">notes above</a>)</p><p class="cR"><strong>Dose </strong>epilepsy, <span class="cP">adult</span> and <span class="cP">child</span> over 20 kg, as above, total daily dose given in 1–2 divided doses</p></div></div><ul class="jT"><li><a href="PHP2990-epilim-chronosphere.htm#PHP2990-epilim-chronosphere" title="Epilim Chronosphere®">Epilim Chronosphere®</a></li><li><a href="PHP2991-episenta.htm#PHP2991-episenta" title="Episenta®">Episenta®</a></li><li><a href="PHP2992-epival.htm#PHP2992-epival" title="Epival®">Epival®</a></li></ul></div><ul class="jT"><li id="_PHP2993-parenteral_PHP2993-parenteral"><a href="PHP2993-parenteral.htm#PHP2993-parenteral" title="Parenteral">Parenteral</a><ul style="display: none"><li><a href="PHP2994-epilim-intravenous.htm#PHP2994-epilim-intravenous" title="Epilim® Intravenous">Epilim® Intravenous</a></li><li><a href="PHP2995-episenta.htm#PHP2995-episenta" title="Episenta®">Episenta®</a></li></ul></li><li id="_PHP2996-valproic-acid_PHP2996-valproic-acid"><a href="PHP2996-valproic-acid.htm#PHP2996-valproic-acid" title="Valproic acid">Valproic acid</a><ul style="display: none"><li><a href="PHP2997-convulex.htm#PHP2997-convulex" title="Convulex®">Convulex®</a></li><li><a href="PHP2998-depakote.htm#PHP2998-depakote" title="Depakote®">Depakote®</a></li></ul></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP2977-valproate.htm">Previous: Valproate</a> | <a class="top" href="PHP2989-epilim-chrono.htm#">Top</a> | <a accesskey="]" href="PHP2999-vigabatrin.htm">Next: Vigabatrin</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>